What is the Medical Morphine Market?

The Medical Morphine Market refers to the pharmaceutical sector dedicated to the production and distribution of morphine-based medications used for pain management in medical settings.

How big is the Medical Morphine Market?

The global Medical Morphine Market size was estimated at USD 23.6 Billion in 2023 and is expected to reach USD 49.1 Billion in 2033.

What is the Medical Morphine Market growth?

The global Medical Morphine Market is expected to grow at a compound annual growth rate of 7.6%. From 2024 To 2033

Who are the key companies/players in the Medical Morphine Market?

Some of the key players in the Medical Morphine Markets are Fresenius Kabi USA, DAIICHI SANKYO COMPANY, Allergan, Pacira BioSciences, Inc., Endo Pharmaceuticals Inc., Tris Pharma, Inc, Purdue Pharma L.P., VERVE HEALTH CARE LTD., Taj Pharmaceuticals Limited, AbbVie Inc., Mallinckrodt Pharmaceuticals, Alcaliber S.A, Sanofi, Johnson Matthey, Northeast Pharmaceutical Group Co., Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Cipla Inc., Mylan N.V.

What drives the growth of the Medical Morphine Market?

The market's growth is primarily driven by the rising prevalence of chronic pain conditions, especially among the aging population, and the presence of key industry players.

What are the key trends in this market?

Emerging trends include a shift towards natural pain management products and advancements in drug delivery systems.

Are there any restraints in the Medical Morphine Market?

Stringent regulatory controls and the negative public perception of opioids due to the opioid epidemic act as restraints in the market.

Global Medical Morphine Market By Route of Administration (Oral, Parenteral, Other Routes of Administration) By Application (Arthritis, Cancer, Myocardial Infarction, Kidney Stones, Diarrhea, Other Applications) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 28053
Number of Pages: 240
Format:

- Fresenius Kabi USA
- DAIICHI SANKYO COMPANY
- Allergan
- Pacira BioSciences, Inc.
- Endo Pharmaceuticals Inc.
- Tris Pharma, Inc
- Purdue Pharma L.P.
- VERVE HEALTH CARE LTD.
- Taj Pharmaceuticals Limited
- AbbVie Inc. Company Profile
- Mallinckrodt Pharmaceuticals
- Alcaliber S.A
- Sanofi Company Profile
- Johnson Matthey
- Northeast Pharmaceutical Group Co., Ltd
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd. Company Profile
- Pfizer Inc Company Profile
- Cipla Inc.
- Mylan N.V.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 28053
Published Date Jan 2024
Rating
- ★★★★★
  
  ★★★★★
- (60)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)